PRESS RELEASE published on 06/14/2024 at 08:01, 1 year 10 months ago Cantourage Group SE records highest monthly revenue in company history in May 2024 Cantourage Group SE achieves record monthly revenue of EUR 3.5 million in May 2024, highest in company history, driven by increased demand for cannabis products post-partial legalization European Market Cantourage Group SE Cannabis Products Legalization Monthly Revenue
BRIEF published on 05/28/2024 at 09:11, 1 year 11 months ago Strategic Partnership Boosts Cantourage Group SE Amid Legislative Shifts NuWays AG Germany Medical Cannabis Cantourage Group SE Portocanna
BRIEF published on 05/28/2024 at 09:11, 1 year 11 months ago Un partenariat stratégique renforce Cantourage Group SE dans un contexte de changements législatifs Allemagne NuWays SA Cannabis Médical Groupe Cantourage SE Porto Canna
PRESS RELEASE published on 05/28/2024 at 09:06, 1 year 11 months ago Original-Research: Cantourage Group SE (von NuWays AG): Kaufen Cantourage Group SE teams up with Portocanna to boost production capacities amid rising demand for medical cannabis in Germany post-legalization changes Germany Medical Cannabis Cantourage Group SE Production Capacities Portocanna
PRESS RELEASE published on 05/17/2024 at 15:46, 1 year 11 months ago Original-Research: Cantourage Group SE (von Montega AG): Kaufen Cantourage Group SE veröffentlicht positive vorläufige Jahreszahlen 2023 und stärkt Produktionskapazitäten für erwartetes Wachstum 2024 im Cannabismarkt Cantourage Group SE Wachstum Jahreszahlen 2023 Cannabismarkt Produktionskapazitäten
BRIEF published on 05/17/2024 at 09:07, 1 year 11 months ago Cantourage Group SE Receives "Buy" Rating from NuWays AG Financial Performance Buy Recommendation Medical Cannabis Cantourage Group SE Market Analysis
BRIEF published on 05/17/2024 at 09:07, 1 year 11 months ago Cantourage Group SE reçoit la note « Acheter » de NuWays AG Performance Financière Recommandation D'achat Analyse De Marché Cannabis Médical Groupe Cantourage SE
PRESS RELEASE published on 05/17/2024 at 09:02, 1 year 11 months ago Original-Research: Cantourage Group SE (von NuWays AG): Kaufen Cantourage Group SE's solid FY23 and Q1 2024 performance revealed slower patient growth due to regulatory changes, but April sales surged by 160%, driven by Cannabis Act impact Cantourage Group SE Sales Acceleration Q1 2024 FY23 Patient Growth
BRIEF published on 05/15/2024 at 08:05, 1 year 11 months ago Cantourage Group SE Achieves Significant Revenue and EBITDA Growth in 2023 Revenue Growth Medical Cannabis Cantourage Group SE Cannabis Legalization EBITDA Improvement
BRIEF published on 05/15/2024 at 08:05, 1 year 11 months ago Cantourage Group SE réalise une croissance significative de son chiffre d'affaires et de son EBITDA en 2023 Légalisation Du Cannabis Hausse Des Revenus Cannabis Médical Amélioration De L'EBITDA Groupe Cantourage SE
Published on 05/09/2026 at 01:30, 8 hours 37 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 10 hours 7 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 13 hours 29 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 14 hours 54 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 15 hours 5 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 14 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 14 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 15 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 15 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
